Suppr超能文献

北印度患者中脂蛋白(a)水平与冠状动脉疾病严重程度的关系

Lipoprotein (a) Levels in Relation to Severity of Coronary Artery Disease in North Indian Patients.

作者信息

Ashfaq Fauzia, Goel Pravin Kumar, Sethi Rishi, Khan Mohd Idrees, Ali Wahid, Idris Mohd Zafar

机构信息

Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.

出版信息

Heart Views. 2013 Jan;14(1):12-6. doi: 10.4103/1995-705X.107114.

Abstract

BACKGROUND

Lipoprotein (a) [Lp (a)] is an established risk marker of coronary artery disease which is independent from other risk factors.

OBJECTIVE

The aim was to address the association between Lp (a) and CAD risk in North Indians. To evaluate whether high levels of lipoprotein (a) [Lp (a)] is a predictor of risk and is related to the severity of CAD.

MATERIALS AND METHODS

This was a cross-sectional study done on 360 patients presenting with chest pain. Coronary angiography revealed CAD in 270 patients and 90 patients without CAD. Lipoprotein (a) level, lipid profile, fasting blood glucose, anthropometric and clinical parameters were analyzed.

RESULTS

Lipoprotein (a) 21.0 mg/dL is associated with the presence of coronary lesions (P = 0.0001). A highly significant difference in Lp (a) levels was observed between normal coronaries vs. single-vessel disease, double-and triple-vessel disease ( P < 0.0001). Body mass index (BMI) was significantly raised in CAD group compared to normal coronary.

CONCLUSION

Multivariate analysis found that Lp (a) was considered an independent predictor for severity of CAD and Lp (a) levels 21.0 mg/dL are associated with severe patterns of coronary atherosclerosis.

摘要

背景

脂蛋白(a)[Lp(a)]是一种已确定的冠状动脉疾病风险标志物,独立于其他风险因素。

目的

旨在探讨北印度人群中Lp(a)与冠心病风险之间的关联。评估脂蛋白(a)[Lp(a)]水平升高是否为风险预测指标,以及是否与冠心病严重程度相关。

材料与方法

这是一项针对360例胸痛患者的横断面研究。冠状动脉造影显示270例患者患有冠心病,90例患者无冠心病。分析了脂蛋白(a)水平、血脂谱、空腹血糖、人体测量和临床参数。

结果

脂蛋白(a)≥21.0mg/dL与冠状动脉病变的存在相关(P=0.0001)。正常冠状动脉组与单支血管病变、双支和三支血管病变组之间的Lp(a)水平存在高度显著差异(P<0.0001)。与正常冠状动脉组相比,冠心病组的体重指数(BMI)显著升高。

结论

多变量分析发现,Lp(a)被认为是冠心病严重程度的独立预测指标,脂蛋白(a)≥21.0mg/dL与严重冠状动脉粥样硬化模式相关。

相似文献

引用本文的文献

6
PCSK9 in chronic kidney disease.慢性肾脏病中的前蛋白转化酶枯草溶菌素9
Int Urol Nephrol. 2017 Jun;49(6):1015-1024. doi: 10.1007/s11255-017-1505-2. Epub 2017 Jan 13.

本文引用的文献

1
The role of hypertriglyceridemia in atherosclerosis.高甘油三酯血症在动脉粥样硬化中的作用。
Curr Atheroscler Rep. 2007 Aug;9(2):110-5. doi: 10.1007/s11883-007-0006-7.
2
Lipoprotein retention--and clues for atheroma regression.脂蛋白潴留——以及动脉粥样硬化消退的线索。
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1536-40. doi: 10.1161/01.ATV.0000174795.62387.d3.
6
Diabetic dyslipidaemia: from basic research to clinical practice.糖尿病血脂异常:从基础研究到临床实践
Diabetologia. 2003 Jun;46(6):733-49. doi: 10.1007/s00125-003-1111-y. Epub 2003 May 28.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验